Monoclonal antibodies (mAbs) have become one of the most important classes of
biopharmaceutical products, and they continue to dominate the universe of …

Behçet's syndrome (BS) is a multisystemic vasculitis, characterized by different clinical
involvements, including mucocutaneous, ocular, vascular, neurological, and gastrointestinal …

Purpose To analyze the factors associated with response (control of ocular inflammation and
corticosteroid-sparing effect) to biologics (anti–tumor necrosis factor [TNF]-α agents and …

Non-infectious uveitis (NIU) represents one of the leading causes of blindness in developed
countries. The therapeutic strategy aims to rapidly control intra-ocular inflammation, prevent …

Introduction: Sarcoidosis is a multi-organ disease with a wide range of clinical
manifestations and outcomes. A quarter of sarcoidosis patients require long-term treatment …

Purpose To study the drug retention rate (DRR), causes, and predictors of discontinuation of
adalimumab (ADA) in a real-world uveitis setting. Design Multicentric, nationwide, registry …

Background To compare the efficacy of Adalimumab (ADA) in noninfectious anterior uveitis
(AU) and posterior segment (PS) involvement, associated with different conditions, with a …

Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to
the employment of biosimilars in clinical practice. The aim of the study was to identify any …

Background Anti-tumor necrosis factor-alpha was regarded as an option in treatment of non-
infectious uveitis. However, few studies in the far easter region have concentrated on this …

Introduction The aim of this nationwide, prospective post-marketing surveillance was to
assess the safety and effectiveness of up to 52 weeks of adalimumab treatment in patients …